Suppression of KSHV lytic replication and primary effusion lymphoma by selective RNF5 inhibition
Sign Up to like & getrecommendations! Published in 2023 at "PLOS Pathogens"
DOI: 10.1371/journal.ppat.1011103
Abstract: Primary effusion lymphoma (PEL), a rare aggressive B-cell lymphoma in immunosuppressed patients, is etiologically associated with oncogenic γ-herpesvirus infection. Chemotherapy is commonly used to treat PEL but usually results in poor prognosis and survival; thus,… read more here.
Keywords: inhibition; lytic replication; kshv lytic; effusion lymphoma ... See more keywords